Toxic effect of ethanol

ST19_TOXIC_EFFECT_ETHAN

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T51.0 Hospital discharge: ICD-9 — 9800 Hospital discharge: ICD-8 — 9800 Cause of death: ICD-10 — T51.0 Cause of death: ICD-9 — 9800 Cause of death: ICD-8 — 9800 2 out of 7 registries used, show all original rules.	1670
4. Check minimum number of events None	1670
5. Include endpoints None	1670
6. Filter based on genotype QC (FinnGen only)	1670

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
Special: ALCOETHTOXIC
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T51
Name in latin: Effectus toxicus alcohol aethylici

NAME	ST19_TOXIC_EFFECT_ETHAN
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T510
HD_ICD_9	9800
HD_ICD_8	9800
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T510
COD_ICD_9	9800
COD_ICD_8	9800
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Toxic effect of ethanol based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23765	8683	14891
Only index persons	19385	7778	11607
Unadjusted period prevalence (%)
Whole population	0.35	0.25	0.42
Only index persons	0.38	0.29	0.44
Median age at first event (years)
Whole population	21.51	15.84	24.50
Only index persons	17.62	15.58	18.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1670	765	905
Unadjusted period prevalence (%)	0.34	0.26	0.40
Median age at first event (years)	23.29	16.15	29.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1512: Matched controls
15118

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

9800A

ICD-9 Finland

Toxic effect of alcohol, Ethyl alcohol

+∞

323.0

326

T51.0

ICD-10 Finland

Toxic effect: Ethanol

+∞

323.0

798

98000

ICD-8 Finland

Toxic effect of alcohol, Ethyl alcohol

+∞

323.0

396

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

404.8

323.0

318

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

12.5

241.9

474

532

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

19.2

229.6

365

246

T36

ICD-10 Finland

Poisoning by systemic antibiotics

15.8

221.7

383

318

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

19.4

122.1

190

111

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

15.6

119.6

203

149

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

38.4

111.9

143

N07BB01

ATC

disulfiram; oral

8.4

108.7

256

357

F10.09

ICD-10 Finland

Alcohol intoxication UNS

15.2

108.3

185

137

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

28.7

106.4

146

N05AH04

ATC

quetiapine; oral

3.9

93.6

478

1616

E8699

ICD-8 Finland

Accidental poisoning by other and unspecified solid and liquid substances

98.3

92.2

101

F10.20

ICD-10 Finland

Alcohol dependence currently independent

14.0

91.9

162

128

F10.25

ICD-10 Finland

Alcohol dependence continuous use

16.6

84.1

138

P15

ICPC

Chronic alcohol abuse

10.2

84.0

174

191

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.0

79.5

377

1172

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

15.1

74.8

127

N05AA02

ATC

levomepromazine; systemic

7.7

74.1

182

264

N05CD07

ATC

temazepam; oral

5.0

73.0

260

607

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

13.3

71.4

128

104

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

27.9

70.5

N05BA01

ATC

diazepam; systemic, rectal

4.0

69.4

319

952

F10.24

ICD-10 Finland

Alcohol depence active use

14.8

68.4

117

E970A

ICD-9 Finland

Injury due to legal intervention by firearms

124.0

66.4

N06AX11

ATC

mirtazapine; oral

2.8

66.2

588

2822

N05BA02

ATC

chlordiazepoxide; systemic

11.8

65.2

124

114

E850A

ICD-9 Finland

Accidental poisoning by analgesics, antipyretics, antirheumatics

76.4

64.7

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

22.4

63.5

N05BA04

ATC

oxazepam; oral

2.9

61.3

472

2050

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

21.4

61.2

B18.2

ICD-10 Finland

Chronic viral hepatitis C

14.6

61.1

105

N05CF01

ATC

zopiclone; oral

2.8

60.8

521

2416

N06AB04

ATC

citalopram; systemic

3.0

60.1

419

1702

P16

ICPC

Acute alcohol abuse

11.3

54.5

105

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

31.4

54.2

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.1

53.7

232

644

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

16.4

53.3

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

17.3

51.3

N06AB03

ATC

fluoxetine; oral

3.4

50.8

276

925

S06.0

ICD-10 Finland

Concussion

3.6

50.6

257

817

N05AH03

ATC

olanzapine; systemic

4.3

49.8

198

506

R56.8

ICD-10 Finland

Other and unspecified convulsions

5.1

49.8

167

358

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

26.9

48.5

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

17.2

48.2

Z72.1

ICD-10 Finland

Alcohol use

11.8

46.3

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

34.0

45.4

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

47.4

45.4

Z2446

NOMESCO Finland

Social worker

4.3

44.8

178

453

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

8.4

44.5

101

128

Y91.1

ICD-10 Finland

Moderate alcohol intoxication

158.0

44.0

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

11.8

42.7

N05AF03

ATC

chlorprothixene; systemic

7.1

42.4

108

163

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

15.2

41.9

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

14.7

40.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

40.2

258

962

Y91.2

ICD-10 Finland

Severe alcohol intoxication

210.5

40.0

N06AX03

ATC

mianserin; oral

5.8

39.3

117

217

N06AA12

ATC

doxepin; systemic

5.5

38.7

120

234

N06AX16

ATC

venlafaxine; oral

2.8

38.4

286

1172

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

38.1

38.0

XF400

NOMESCO Finland

ECG with 12 standard connections

2.8

37.2

276

1126

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

37.1

247

940

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

36.7

191

610

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

36.3

446

2373

N05BE01

ATC

buspirone; oral

6.3

36.2

165

F10.05

ICD-10 Finland

Alcohol-related acute intoxication with coma

70.0

36.1

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.0

36.0

233

868

AA1AD

NOMESCO Finland

CT of head and brain

2.5

35.6

335

1562

V03AA01

ATC

8.9

35.4

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.3

34.8

188

617

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

34.7

349

1680

N06AB10

ATC

escitalopram; oral

2.3

34.6

378

1895

N05AB01

ATC

dixyrazine; systemic

13.6

33.9

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.0

33.8

210

760

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.3

33.7

130

320

N05AX08

ATC

risperidone; systemic

3.4

33.5

173

548

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.2

33.4

133

337

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

15.9

33.1

T51.9

ICD-10 Finland

Toxic effect: Alcohol, unspecified

119.3

32.8

S01.0

ICD-10 Finland

Open wound of scalp

3.5

32.7

163

502

N03AE01

ATC

clonazepam; systemic

4.3

32.4

127

317

Z72.2

ICD-10 Finland

Drug use

18.4

32.4

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

5.0

32.2

108

230

N06AB06

ATC

sertraline; oral

2.7

31.0

230

929

E9809

ICD-8 Finland

Poisoning by solid or liquid substances, undetermined whether accidentally or purposely inflicted, Other and unspecified solid and liquid substances

86.9

30.8

N03AG01

ATC

valproic acid; systemic, rectal

3.5

30.3

152

470

P19

ICPC

Drug abuse

9.6

30.0

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.2

30.0

107

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

37.9

29.4

TKC20

NOMESCO Finland

Catheterisation of bladder

3.8

28.9

129

362

N05BA12

ATC

alprazolam; oral

3.0

28.7

179

648

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

10.7

27.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

27.8

196

765

T74.1

ICD-10 Finland

Physical abuse

5.8

27.8

143

SPAT1265

SPAT

Breathalyser

10.5

27.6

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

30.7

27.3

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

13.0

27.2

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

17.0

27.2

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

20.5

27.0

N05AD01

ATC

haloperidol; systemic

5.7

27.0

144

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

12.7

26.9

Z3231

NOMESCO Finland

Registered nurse

2.0

26.1

408

2348

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

17.8

25.8

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

24.5

25.7

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

19.0

25.7

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

33.7

25.6

C07AA05

ATC

propranolol; systemic

2.1

25.5

320

1680

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

12.8

25.4

F61.0

ICD-10 Finland

Mixed personality disorders

6.2

24.8

114

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

16.6

24.6

N03AF01

ATC

carbamazepine; oral, rectal

4.0

24.4

100

260

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

12.2

24.3

P29

ICPC

Psychological sympt/compl other

3.0

23.6

148

533

P18

ICPC

Medication abuse

11.9

23.5

R40.2

ICD-10 Finland

Coma, unspecified

12.3

23.3

WX730

NOMESCO Finland

Conventional respirator

7.9

23.1

K92.0

ICD-10 Finland

Haematemesis

5.9

23.1

117

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

22.4

23.1

F60.2

ICD-10 Finland

Dissocial personality disorder

17.9

22.7

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.6

22.4

178

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

22.3

194

851

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

22.1

315

1735

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.3

22.0

200

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

18.7

21.8

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

5.8

21.7

110

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.5

21.7

N05AA01

ATC

chlorpromazine; systemic, rectal

7.7

21.5

30180

ICD-8 Finland

Personality disorders, Immatura

17.7

21.4

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.4

21.4

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

7.6

21.3

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

34.3

21.1

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

12.1

21.1

N05AX12

ATC

aripiprazole; systemic

3.2

21.1

114

373

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.0

21.0

140

P99

ICPC

Psychological disorders other

4.3

21.0

195

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

20.8

522

3493

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

42.3

20.5

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

25.9

20.5

ZY010

NOMESCO Finland

Hospital outpatient

3.0

20.4

123

433

N06AA06

ATC

trimipramine; systemic

5.6

20.2

108

Z2221

NOMESCO Finland

Medical doctor

1.8

20.1

403

2502

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

13.9

20.1

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.6

20.0

158

657

N03AX09

ATC

lamotrigine; oral

3.1

20.0

116

399

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

21.1

20.0

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

8.2

19.8

A06AD11

ATC

lactulose; oral

2.4

19.7

175

772

Y91.0

ICD-10 Finland

Mild alcohol intoxication

74.5

19.7

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

29.3

19.7

N05AB03

ATC

perphenazine; systemic, rectal

3.8

19.2

222

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

14.2

19.1

N02AX02

ATC

tramadol; systemic, rectal

1.7

18.9

535

3689

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

12.0

18.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

18.7

224

1140

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

18.7

106

358

30399

ICD-8 Finland

Other and unspecified alcoholism

38.9

18.6

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.0

18.6

124

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

13.0

18.4

F92.0

ICD-10 Finland

Depressive conduct disorder

13.0

18.4

X78

ICD-10 Finland

Intentional self-harm by sharp object

9.2

18.4

N04AA02

ATC

biperiden; systemic

5.4

18.4

104

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.7

18.4

129

501

W19

ICD-10 Finland

Unspecified fall

2.5

18.3

155

667

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

7.5

18.3

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

13.7

18.3

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

9.5

18.2

N06AB05

ATC

paroxetine; oral

2.9

17.9

116

428

WX892

NOMESCO Finland

Monitored bed care

2.7

17.7

125

487

N07BA03

ATC

varenicline; oral

2.9

17.7

113

414

F51.0

ICD-10 Finland

Nonorganic insomnia

2.1

17.7

217

1115

EBA00

NOMESCO Finland

Extraction of tooth

1.7

17.7

525

3650

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

17.2

17.4

R51.80

ICD-10 Finland

Headache

2.0

17.4

237

1272

N05AH02

ATC

clozapine; systemic

4.2

17.4

161

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

17.4

135

554

SPAT1227

SPAT

Substance abuse rehabilitation

8.6

17.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.9

16.9

106

382

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

16.6

296

M79.6

ICD-10 Finland

Pain in limb

1.7

16.4

449

3035

Y90.8

ICD-10 Finland

Blood alcohol level of 240 mg/100 ml or more

23.3

16.4

S00.0

ICD-10 Finland

Superficial injury of scalp

5.1

16.3

102

V03AB30

ATC

11.3

16.3

30041

ICD-8 Finland

Neuroses, Depressiva

8.9

16.2

30188

ICD-8 Finland

Personality disorders, Alia definita

18.7

16.0

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.2

16.0

150

A46

ICD-10 Finland

Erysipelas

2.1

15.9

182

906

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

14.7

15.8

R41.0

ICD-10 Finland

Disorientation, unspecified

4.9

15.8

106

N05AD03

ATC

melperone; systemic

6.6

15.7

Z71.8

ICD-10 Finland

Other specified counselling

1.7

15.7

362

2324

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

15.6

335

2103

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

4.2

15.6

144

Y07

ICD-10 Finland

Other maltreatment

7.8

15.4

N05CF02

ATC

zolpidem; oral

1.9

15.3

241

1362

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

28.9

15.2

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.5

15.2

120

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.6

15.0

117

481

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

14.9

510

3644

S18

ICPC

Laceration/cut

1.6

14.9

517

3706

X84

ICD-10 Finland

Intentional self-harm by unspecified means

12.6

14.9

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

14.9

372

SPAT1254

SPAT

Administration of medicine

2.0

14.8

212

1155

N06AG02

ATC

moclobemide; oral

3.3

14.6

232

X65

ICD-10 Finland

Intentional self-poisoning by and exposure to alcohol

+∞

14.6

T51.1

ICD-10 Finland

Toxic effect: Methanol

80.9

14.6

Y90.7

ICD-10 Finland

Blood alcohol level of 200-239 mg/100 ml

36.4

14.4

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.0

14.4

146

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.2

14.3

132

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

11.5

14.3

P74

ICPC

Anxiety disorder/anxiety state

2.9

14.3

322

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

14.3

107

432

N03AX16

ATC

pregabalin; oral

1.8

14.2

295

1827

X58

ICD-10 Finland

Exposure to other specified factors

1.9

14.2

218

1220

N06AX05

ATC

trazodone; oral

4.0

14.2

143

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

14.1

122

532

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

42.9

14.1

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

42.9

14.1

V01.9

ICD-10 Finland

Pedestrian injured in collision with pedal cycle, Unspecified whether traffic or nontraffic accident

14.6

14.1

N06AA09

ATC

amitriptyline; systemic

2.4

14.0

120

519

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

10.2

14.0

ZXD05

NOMESCO Finland

Urgent procedure

1.6

14.0

432

2997

2913A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal hallucinosis

53.8

13.8

F92.9

ICD-10 Finland

Mixed disorder of conduct and emotions, unspecified

24.0

13.8

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

8.7

13.8

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

10.6

13.7

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

13.7

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.2

13.7

W10

ICD-10 Finland

Fall on and from stairs and steps

3.0

13.6

266

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

13.6

121

535

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.4

13.6

195

ZXD35

NOMESCO Finland

Usual procedure

3.7

13.6

169

T68

ICD-10 Finland

Hypothermia

14.9

13.6

Y91.3

ICD-10 Finland

Very severe alcohol intoxication

+∞

13.6

S82.6

ICD-10 Finland

Fracture of lateral malleolus

2.7

13.5

358

97940

ICD-8 Finland

Alcohol in combination with specified medicinal agents, With psychopharmacological agents

34.3

13.5

SPAT1247

SPAT

Outpatient detoxication and monitoring

8.9

13.5

X57

ICD-10 Finland

Unspecified privation

3.9

13.4

141

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

26.0

13.4

E8599

ICD-8 Finland

Accidental poisoning by other and unspecified drugs and medicaments, Drugs, unspecified

21.3

13.3

R53

ICD-10 Finland

Malaise and fatigue

1.8

13.3

265

1617

D10

ICPC

Vomiting

2.4

13.3

119

528

Z2445

NOMESCO Finland

Psychologist

2.8

13.3

325

R11

ICD-10 Finland

Nausea and vomiting

2.3

13.2

123

554

EBA30

NOMESCO Finland

Excision of root of tooth

2.8

13.2

313

C03CA01

ATC

furosemide; systemic

1.8

13.1

245

1462

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.2

13.1

218

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.8

13.1

149

P76

ICPC

Depressive disorder

2.4

13.0

114

500

P03

ICPC

Feeling depressed

2.0

13.0

169

887

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.3

13.0

111

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.2

12.9

116

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

12.9

121

547

P01AB01

ATC

metronidazole; oral, rectal

1.5

12.8

497

3630

Y04.0

ICD-10 Finland

Assault by bodily force by spouse or partner

11.7

12.8

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

10.6

12.8

-1

NOMESCO Finland

1.5

12.7

521

3853

A02BC02

ATC

pantoprazole; systemic

1.5

12.7

790

6404

F10.04

ICD-10 Finland

Alcohol-related acute intoxication with hallucinations

70.4

12.6

E9599

ICD-8 Finland

Late effect of self-inflicted injury

32.3

12.6

Z3226

NOMESCO Finland

Physiotherapist

1.8

12.6

237

1419

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

12.5

313

E947X

ICD-9 Finland

Other and unspecified drugs and medicaments[MUUT MÄÄRITTELEM LÄÄKKEET/LÄÄKKEENOM KÄYT AIN]

+∞

12.5

29120

ICD-8 Finland

Alcoholic psychosis, Other alcoholic hallucinosis

+∞

12.5

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

12.5

767

6189

Z72.0

ICD-10 Finland

Tobacco use

3.5

12.5

171

2918A

ICD-9 Finland

Alcoholic psychoses, Other specified alcoholic psychosis

24.5

12.5

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

20.2

12.5

F31

ICD-10 Finland

Bipolar affective disorder

5.0

12.4

N05AN01

ATC

lithium; oral

3.4

12.3

173

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.0

12.3

127

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

4.8

12.3

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.4

12.3

N03AX12

ATC

gabapentin; oral

1.9

12.2

188

1049

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

12.2

222

1312

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

16.0

12.1

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.9

12.1

N05CD02

ATC

nitrazepam; oral

6.6

12.0

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

21.5

12.0

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

21.5

12.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

11.9

149

768

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

13.5

11.9

V03AA02

ATC

47.0

11.9

N06AX12

ATC

bupropion; oral

2.3

11.8

114

525

WX290

NOMESCO Finland

Other blockade of nerve

1.5

11.8

697

5558

Y09

ICD-10 Finland

Assault by unspecified means

9.0

11.8

SPAT1240

SPAT

Therapeutic discussion

1.9

11.7

186

1051

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

11.7

259

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

11.5

399

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

3.2

11.5

199

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.8

11.5

278

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

9.3

11.5

G72.8

ICD-10 Finland

Other specified myopathies

5.7

11.5

9693X

ICD-9 Finland

Poisoning by psychotropic agents, Other antipsychotics, neuroleptics and major tranquillisers

+∞

11.5

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.6

11.4

146

WX110

NOMESCO Finland

Local anesthesy

1.5

11.4

999

8595

A01

ICPC

Pain general/multiple sites

2.3

11.4

106

478

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.4

11.3

408

N80

ICPC

Head injury other

4.9

11.3

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.4

11.3

N02BE01

ATC

paracetamol; systemic, rectal

1.5

11.3

1144

10149

85000

ICD-8 Finland

Concussion, Current or unspecified

3.7

11.2

133

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

11.2

301

1993

F10.07

ICD-10 Finland

Pathological alcohol intoxication

17.2

11.2

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

4.6

11.2

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

7.7

11.2

B17.1

ICD-10 Finland

Acute hepatitis C

25.2

11.1

96798

ICD-8 Finland

Other sleeping pills and sedatives

25.2

11.1

P06

ICPC

Sleep disturbance

2.0

11.1

143

747

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.3

11.1

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020191) Ethanol [Moles/volume] in Serum or Plasma

153

128

13.06

154.57

2.7

1.4

promille

2.1

1.2

5.48

106

103

(3028707) Methadone [Presence] in Urine by Screen method

237

443

6.07

123.91

6.4

3.0

—

(4198724)

113

12.29

111.15

4.6

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

286

805

4.08

90.29

5.8

2.2

—

(3016879) Cocaine [Presence] in Urine

307

956

3.71

83.47

6.0

2.2

—

(3011288) Drugs identified in Urine by Screen method

254

693

4.14

83.37

8.9

3.0

—

(3000764) Benzodiazepines [Presence] in Urine

315

1021

3.57

80.42

5.9

2.2

—

(3028300) Cannabinoids [Presence] in Urine

316

1033

3.54

79.57

6.0

2.2

—

(3027008) Opiates [Presence] in Urine

311

1030

3.48

76.54

5.2

2.2

—

(3027944) Amphetamines [Presence] in Urine

304

1010

3.46

74.31

5.3

2.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

10.53

59.33

2.2

4.0

umol/l

196.3

154.2

0.27

(3002032) Base excess in Venous blood by calculation

275

995

3.11

57.53

5.5

4.2

mmol/l

1.4

1.9

1.02

212

781

(3021447) Carbon dioxide [Partial pressure] in Venous blood

276

1003

3.10

57.29

4.8

4.2

kpa

6.0

5.9

0.78

260

968

(3000991) Gas panel - Venous blood

258

930

3.10

54.14

10.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

241

838

3.19

53.76

4.4

3.4

kpa

5.0

4.7

0.74

224

808

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

459

2238

2.45

53.25

3.0

1.8

1.7

1.4

9.63

401

2020

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

100

7.48

49.40

2.0

1.6

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

901

6082

2.05

44.09

6.8

6.2

umol/l

10.6

11.3

0.80

845

5768

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

15.11

41.74

1.2

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

752

4839

2.01

41.20

9.0

6.3

mmol/l

1.2

4.86

701

4403

(3014111) Lactate [Moles/volume] in Serum or Plasma

242

976

2.73

40.74

9.7

8.4

mmol/l

1.6

1.4

2.27

233

939

(3003396) Base excess in Arterial blood by calculation

275

1199

2.55

39.48

9.2

9.3

mmol/l

0.7

1.1

0.66

211

944

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

165

550

3.22

39.08

6.2

4.7

mmol/l

23.6

24.1

1.44

145

498

(3027801) Oxygen [Partial pressure] in Arterial blood

273

1205

2.51

38.11

9.2

kpa

11.8

12.5

1.22

259

1160

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

273

1205

2.51

38.11

9.3

9.2

kpa

5.2

5.1

0.24

258

1155

(3014576) Chloride [Moles/volume] in Serum or Plasma

299

1377

2.43

38.06

9.9

7.6

mmol/l

104.4

0.04

292

1352

(3042517) Benzodiazepines panel - Urine

15.02

34.85

2.6

2.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

682

4447

1.90

34.11

4.4

3.3

u/l

36.8

32.3

1.84

644

4234

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

600

3753

1.93

34.04

3.3

2.6

u/l

58.8

57.3

0.11

560

3498

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

786

5387

1.87

33.44

8.7

6.9

mmol/l

1.2

4.26

696

4575

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

6.84

31.96

1.9

1.7

iu/ml

2043400.0

1356693.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

139

5.06

31.60

5.6

2.1

—

(3016502) Oxygen saturation in Arterial blood

241

1092

2.41

31.43

10.1

9.7

95.2

95.8

0.97

232

1055

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

541

3340

1.92

31.41

3.0

2.2

u/l

326.2

304.3

0.12

517

3156

(3013826) Glucose [Moles/volume] in Serum or Plasma

960

7115

1.82

30.67

7.3

4.9

mmol/l

6.8

6.6

1.65

906

6564

(3002173) Hemoglobin [Mass/volume] in Arterial blood

224

1021

2.38

28.70

10.7

9.9

g/l

126.5

124.4

0.73

215

985

(3023183) Ammonium ion [Moles/volume] in Plasma

284

3.49

26.66

2.7

3.6

umol/l

31.4

35.6

1.03

239

(3023368) Bacteria identified in Blood by Culture

482

2999

1.85

26.50

5.5

4.3

—

(3033658) Prothrombin time (PT) actual/Normal

484

3023

1.85

26.25

5.9

4.1

90.8

92.5

0.79

469

2952

(3009508) Creatinine [Moles/volume] in Urine

549

3639

1.76

23.99

5.8

3.3

mmol/l

7.6

8.5

3.78

485

3110

(3024561) Albumin [Mass/volume] in Serum or Plasma

676

4753

1.71

23.86

5.7

5.0

g/l

35.7

36.5

2.66

631

4449

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1152

9367

1.74

23.38

8.7

7.2

u/l

78.0

75.9

0.90

1107

8843

(3003458) Phosphate [Moles/volume] in Serum or Plasma

267

1434

2.03

22.40

6.7

6.9

mmol/l

1.1

1.0

0.50

257

1351

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

131

4.39

22.14

14.7

14.6

nmol/l

823.9

820.9

0.01

126

(3012095) Magnesium [Moles/volume] in Serum or Plasma

314

1809

1.91

21.41

3.8

mmol/l

0.8

2.19

294

1714

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

225

1154

2.10

21.33

3.9

2.6

u/l

29.6

81.0

0.68

185

997

(40758558) Short blood count panel - Blood

473

3099

1.73

21.02

8.6

6.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

135

563

2.52

20.83

12.5

12.3

mmol/l

23.7

24.4

1.45

126

538

(3009466) Valproate [Moles/volume] in Serum or Plasma

236

3.33

20.11

5.4

5.7

umol/l

401.4

366.6

1.10

206

(3018418) pH of Serum or Plasma

475

3148

1.71

20.10

5.3

4.1

7.4

0.43

620

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

117

463

2.64

20.10

5.7

3.5

52.7

49.6

0.58

117

456

(3020779) Urea [Moles/volume] in Serum or Plasma

196

991

2.11

19.22

7.9

9.0

mmol/l

8.5

8.7

0.17

182

948

(3008152) Bicarbonate [Moles/volume] in Arterial blood

144

649

2.33

18.72

8.3

8.0

mmol/l

24.2

24.4

0.28

131

605

(1761868) Lipid panel - Serum or Plasma

363

5408

0.58

18.29

2.7

2.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

339

2102

1.77

17.92

1.9

1.6

—

(3042936) Bacteria identified in Isolate by Culture

289

1716

1.83

17.64

2.2

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

223

1226

1.95

17.26

2.2

1.8

—

(3020891) Body temperature

102

407

2.60

17.23

8.3

4.8

—

(3019060) Gas panel - Arterial blood

143

667

2.25

17.13

5.7

5.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

307

2.83

16.82

5.2

4.3

mmol/l

3.8

3.9

0.88

287

(3021960) Folate [Moles/volume] in Serum or Plasma

367

2373

1.70

16.57

1.5

nmol/l

18.2

19.9

1.76

328

2058

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

100

404

2.57

16.48

1.9

2.5

ug/l

530.6

487.4

0.06

375

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

217

1207

1.92

16.18

2.2

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

289

1759

1.78

16.14

2.2

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

917

7408

1.53

15.74

12.0

8.9

e9/l

4.5

4.0

5.77

793

6497

(3018677) aPTT in Platelet poor plasma by Coagulation assay

283

1724

1.77

15.73

2.2

2.3

29.9

29.7

0.25

278

1675

(3044640) Blood type and Crossmatch panel - Blood

536

3866

1.57

15.39

2.6

2.3

—

(3030467) Casts [#/volume] in Urine by Automated count

461

3214

1.60

15.30

3.6

2.9

e6/l

0.4

0.28

356

2408

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

429

2946

1.61

15.13

2.5

2.2

—

(3026008) Bacteria identified in Urine by Culture

440

3054

1.60

14.80

3.1

2.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

987

8160

1.51

14.74

5.0

3.8

e6/l

312.2

999.4

0.48

107

(3032080) INR in Blood by Coagulation assay

588

4362

1.54

14.74

7.8

7.9

inr

1.1

1.2

2.10

158

1369

(36304419) Bacteria [Presence] in Urine

453

3182

1.58

14.42

3.5

2.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

126

606

2.17

13.99

12.7

12.5

—

(3019150) Specific gravity of Urine by Refractometry

405

2792

1.59

13.89

4.9

3.2

kg/l

1.0

0.09

380

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

137

689

2.08

13.55

1.6

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

489

3542

1.54

13.42

3.5

3.0

e6/l

32.0

82.6

1.55

382

2722

(3011397) Hemoglobin [Presence] in Urine by Test strip

401

2789

1.58

13.15

4.0

3.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

244

1501

1.73

12.96

2.0

1.7

—

(3017509) Phencyclidine [Presence] in Urine

8.97

12.90

3.5

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

10.85

12.86

7.2

8.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

159

859

1.94

12.86

3.0

2.3

ug/l

5.8

8.3

1.69

141

769

(3018095) Leukocytes [#/volume] in Urine

567

4276

1.49

12.71

4.1

3.4

e6/l

20.2

70.1

4.06

400

2943

(3024928) Oxygen saturation in Venous blood

236

2.78

12.66

2.5

3.1

—

(3000850) Epithelial cells [#/volume] in Urine

354

2418

1.59

12.47

2.9

2.5

e6/l

5.8

6.2

0.21

314

2135

(44816559) Phosphatidylethanol [Mass/volume] in Blood

366

2.39

12.27

1.8

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

293

1925

1.63

12.08

2.9

2.6

e6/l

1.3

0.9

0.68

168

1083

(3015377) Calcium [Moles/volume] in Serum or Plasma

492

3645

1.50

11.88

3.2

mmol/l

2.3

0.04

432

3268

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1654

0.44

11.64

1.4

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

269

1755

1.64

11.36

1.7

nmol/l

1204.5

1142.7

0.53

205

1364

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

309

2093

1.58

11.17

4.7

3.4

ng/l

777.4

594.5

0.17

203

1425

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

563

4337

1.45

10.96

2.1

1.8

pmol/l

94.7

95.8

0.23

313

2414

(46235355) HIV 1 and 2 tests - Meaningful Use set

516

3911

1.46

10.93

2.6

2.0

—

(42870588) Differential panel, method unspecified - Blood

552

4238

1.45

10.93

6.5

6.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

122

637

1.99

10.89

2.0

1.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1103

9605

1.44

10.73

5.1

3.0

u/l

57.3

45.1

3.27

1057

9150

(3001604) Monocytes [#/volume] in Blood

787

6468

1.41

10.58

6.5

5.9

e9/l

0.6

4.53

675

5675

(3006315) Basophils [#/volume] in Blood

789

6491

1.41

10.52

6.5

5.9

e9/l

0.0

2.30

679

5689

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

179

1070

1.75

10.45

2.7

2.4

g/l

0.2

2.07

163

997

(3013115) Eosinophils [#/volume] in Blood

812

6727

1.40

10.33

7.7

6.2

e9/l

0.2

1.17

715

5985

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

112

581

1.99

10.19

1.6

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

116

611

1.97

10.11

2.0

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

809

6728

1.39

9.91

6.5

5.9

e9/l

2.1

2.0

0.79

716

6014

(3022217) INR in Platelet poor plasma by Coagulation assay

193

1196

1.69

9.89

10.4

20.0

inr

1.1

1.2

0.93

179

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

731

5980

1.40

9.86

4.4

4.0

—

(3052851) Hemolysis interference index of Serum or Plasma

332

2.29

9.77

2.9

3.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

541

4206

1.42

9.77

4.3

3.2

ng/l

30.3

42.5

1.27

345

2527

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

608

4842

1.40

9.51

2.3

2.2

nmol/l

70.7

72.8

0.92

554

4453

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

218

1409

1.63

9.49

3.5

2.9

umol/l

10.7

8.0

0.58

182

1214

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

389

2860

1.47

9.43

3.2

2.2

—

(3026782) Osmolality of Urine

320

2267

1.51

9.31

3.1

2.6

mosm/kgh2o

501.7

570.7

5.47

280

1951

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

246

1648

1.58

9.21

2.4

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

357

2596

1.48

9.12

2.9

2.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

415

3109

1.45

9.07

2.0

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

177

1098

1.68

9.03

2.2

2.9

1.7

0.06

150

990

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

122

3.08

9.00

14.4

10.8

mmol/l

0.6

0.53

111

(40761535) Cells panel - Urine sediment

150

890

1.75

8.98

3.6

3.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

242

2.40

8.56

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

202

1321

1.60

8.36

2.2

1.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

262

1826

1.52

8.17

3.1

2.7

e6/l

3.4

2.2

0.86

139

992

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

368

2.06

7.62

1.4

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

258

1820

1.49

7.56

3.4

2.9

mmol/l

2.4

0.69

223

1606

(3021879) Hepatitis B virus core Ab [Presence] in Serum

203

1361

1.56

7.54

1.8

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1000

8810

1.34

7.52

4.6

3.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1418

13221

1.48

7.49

21.4

13.0

mmol/l

139.4

139.6

3.07

1384

12858

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1140

0.46

7.49

1.1

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1113

9972

1.35

7.41

4.3

3.7

pmol/l

14.5

0.01

1032

9172

(3016650) Hepatitis A virus Ab [Presence] in Serum

259

2.24

7.38

1.2

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

116

678

1.76

7.34

5.3

3.5

mmol/l

1.5

0.03

502

(3039443) Prostate specific Ag panel - Serum or Plasma

369

0.21

7.27

1.6

—

(3022096) Basophils/100 leukocytes in Blood

703

5909

1.33

7.23

6.8

6.1

0.7

0.39

662

5550

(3023520) Reticulocytes [#/volume] in Blood

128

779

1.70

7.02

2.1

2.9

e9/l

72.3

70.9

0.17

587

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

288

2.12

6.81

1.6

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

723

6149

1.31

6.67

7.2

6.3

8.3

8.5

0.48

683

5794

(3023103) Potassium [Moles/volume] in Serum or Plasma

1417

13278

1.44

6.63

21.4

13.1

mmol/l

3.9

4.0

1.90

1375

12894

(3009343) pH of Capillary blood

117

709

1.70

6.53

5.3

3.4

7.4

0.11

(3018010) Neutrophils/100 leukocytes in Blood

736

6298

1.30

6.40

6.9

5.8

57.6

56.6

1.61

695

5937

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

375

2917

1.37

6.32

2.5

2.0

mg/l

2.7

2.8

0.24

319

2487

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

341

2614

1.38

6.29

3.2

3.0

ng/l

1267.9

1263.9

0.01

283

2181

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

175

1184

1.53

6.23

4.6

3.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

364

2828

1.37

6.17

1.7

1.9

mg/l

1.5

1.0

1.08

266

2073

(3006504) Eosinophils/100 leukocytes in Blood

714

6111

1.29

6.11

7.0

6.0

2.8

0.17

672

5727

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

257

2.10

5.90

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

508

1.77

5.86

1.5

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

741

6397

1.28

5.85

6.9

6.0

27.6

28.9

2.49

698

6016

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

191

1335

1.49

5.83

9.5

5.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

188

2621

0.68

5.73

2.2

2.7

ug/l

0.6

0.7

1.81

126

1550

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

121

770

1.62

5.63

1.8

1.7

—

(3021589) Normoblasts [#/volume] in Blood

673

5767

1.28

5.55

10.7

8.8

e9/l

0.0

0.17

550

4735

(3000494) Fungus identified in Specimen by Culture

209

1504

1.45

5.50

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

429

1.81

5.47

6.1

6.6

0.8

0.9

1.38

400

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

296

2289

1.36

5.10

1.6

pmol/l

462.8

38625294.4

2.62

253

1978

(3036180) Methadone [Presence] in Urine

13.39

5.08

2.1

2.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

234

1747

1.39

5.00

2.6

2.5

umol/l

13.1

14.1

1.07

212

1618

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1417

13425

1.37

4.93

19.0

12.0

mg/l

23.6

22.7

0.51

1201

10387

(3007566) Smooth muscle Ab [Titer] in Serum

384

1.80

4.92

1.5

1.3

titre

60.0

83.3

—

(3010421) pH of Blood

320

1.87

4.85

4.6

4.3

7.4

0.87

266

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

131

2.39

4.83

1.2

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

432

1.75

4.79

6.1

6.5

2.5

1.7

3.78

402

(21494755) Public health laboratory ask at order entry panel

134

1929

0.67

4.79

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

331

1.84

4.69

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

214

2.04

4.54

1.8

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

215

1610

1.38

4.51

2.7

2.5

g/l

2.3

2.4

0.28

192

1494

(3036489) Thrombin time

497

1.66

4.40

2.2

2.5

20.9

21.3

0.34

440

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1219

12936

0.79

4.40

4.1

3.8

mmol/l

1.4

0.49

1146

12170

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1168

12452

0.79

4.35

3.8

3.5

mmol/l

1.4

1.3

1.66

1097

11704

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

442

1.68

4.19

1.5

2.0

g/l

1.5

0.13

385

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

116

2.35

4.09

1.3

2.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1229

13000

0.79

4.08

4.2

3.9

mmol/l

4.5

4.7

5.05

1151

12288

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

296

1.82

4.03

1.2

1.7

e6/l

69332.4

1288.7

0.48

236

(3019832) Treponema pallidum Ab [Presence] in Serum

292

2338

1.30

3.91

1.9

1.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1012

9298

1.22

3.91

3.6

3.7

mm/h

11.0

9.8

1.86

934

8655

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

420

1.67

3.90

2.2

ug/l

2.1

1.9

0.06

380

(3028626) Oxygen [Partial pressure] in Capillary blood

263

1.85

3.88

4.5

2.9

kpa

8.7

8.5

0.31

244

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

196

1485

1.36

3.84

2.8

2.6

22.6

24.2

0.85

167

1284

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

370

1.70

3.78

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

296

1.78

3.73

1.2

1.6

e6/l

20.1

10.6

0.34

226

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

224

1.90

3.70

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

224

1.90

3.70

1.5

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.81

3.69

2.2

3.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.13

3.65

3.0

3.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

102

693

1.50

3.64

4.8

4.5

ng/l

101.4

85.9

0.40

619

(3012516) Albumin [Mass/volume] in Urine

366

3045

1.26

3.59

3.4

mg/l

291.4

274.2

0.03

233

2074

(3007463) Buprenorphine [Presence] in Urine

6.18

3.50

3.3

4.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

382

3203

1.25

3.50

4.1

mg/mmol

14.9

9.9

0.72

243

2150

(3051611) Lipemic interference index of Serum or Plasma

2.38

3.49

3.3

4.5

—

(3012501) Base excess in Blood by calculation

268

1.78

3.38

4.3

4.6

mmol/l

2.3

2.4

0.08

164

(3014765) Yersinia sp identified in Stool by Organism specific culture

375

1.65

3.36

1.1

—

(1616796) Gas panel - Central venous blood

263

1.77

3.29

4.5

3.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

378

1.64

3.27

1.1

1.2

—

(3022313) Gas panel - Capillary blood

513

1.55

3.26

5.4

3.7

—

(3047181) Lactate [Moles/volume] in Blood

355

1.66

3.26

6.7

7.7

mmol/l

1.6

1.3

1.02

310

(3044889) 12 lead EKG panel

925

8508

1.20

3.23

3.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.17

3.21

3.0

3.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.17

3.21

3.0

3.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1262

11964

1.22

3.14

5.1

4.3

mu/l

1.8

2.0

1.25

1188

11145

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

295

3542

0.80

3.12

3.5

3.6

22.1

21.4

0.24

114

1463

(40767503) Oxygen content in Capillary blood by calculation

231

1.79

3.10

3.1

2.5

16.3

16.9

0.28

120

(3035350) Ketones [Presence] in Urine by Test strip

704

6337

1.19

3.09

3.8

3.1

estimate

0.0

0.80

126

1246

(4010399)

112

805

1.42

3.04

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

673

6044

1.19

3.01

2.9

2.8

ug/l

97.1

110.6

1.05

628

5662

(3021901) Oxygen saturation in Capillary blood

197

1.85

2.99

3.0

2.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

227

1.78

2.96

1.2

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

343

1.62

2.91

2.5

3.1

—

(3039000) Anion gap in Blood

244

1.74

2.88

8.2

9.5

mmol/l

12.9

11.4

1.20

219

(3018572) Chloride [Moles/volume] in Blood

245

1.73

2.85

8.2

9.4

mmol/l

103.6

105.5

0.95

220

(3051651) Icteric interference index of Serum or Plasma

2.38

2.73

3.8

4.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

698

6332

1.18

2.69

5.2

4.2

estimate

0.0

0.50

130

1284

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

235

1.72

2.66

1.1

iu/ml

1.0

99.8

—

(3034770) Mitochondria Ab [Titer] in Serum

392

1.55

2.64

1.3

—

893.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

565

1.46

2.62

1.1

—

0.7

—

(3009261) Glucose [Presence] in Urine by Test strip

702

6387

1.17

2.58

3.9

3.1

estimate

0.0

0.80

122

1219

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

155

1207

1.31

2.58

3.5

4.4

u/l

223.2

237.3

1.18

149

1142

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

101

736

1.40

2.57

2.5

2.7

ng/l

167.3

164.7

0.03

651

(3008295) Osmolality of Serum or Plasma

121

2.00

2.56

1.5

1.4

mosm/kgh2o

291.2

286.5

0.39

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

388

4450

0.83

2.55

3.5

4.1

ug/l

1.8

2.3

1.20

345

4033

(3002621) Streptococcal DNAse B [Units/volume] in Serum

7.16

2.55

1.0

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

285

1.63

2.53

1.2

1.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

2.33

2.48

1.1

1.5

—

74.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

342

1.57

2.48

1.5

1.4

ug/g

215.0

302.0

1.76

195

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.21

2.47

1.3

1.4

e6/l

41202.8

25758.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.56

2.44

2.7

2.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

677

0.63

2.43

2.0

—

(3011648) Oxygen content in Venous blood

2.10

2.43

2.3

2.9

10.2

11.7

0.60

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

219

1.71

2.42

1.5

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

114

857

1.35

2.42

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.62

2.36

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

112

1.98

2.31

1.1

1.2

u/l

82.1

58.7

0.43

(4034850)

389

1.51

2.30

6.9

8.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

880

0.68

2.29

1.5

1.6

—

(3045788) Cell count panel - Pleural fluid

2.23

2.28

1.3

1.4

—

(3003181) Sodium [Moles/volume] in Urine

149

1.83

2.25

3.9

1.3

mmol/l

60.6

70.2

0.34

123

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

107

1.97

2.20

4.6

3.9

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

120

925

1.32

2.18

2.5

2.4

ml/min/173m2

75.3

74.3

0.08

339

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

159

1.77

2.14

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

2.06

2.11

1.3

1.4

e6/l

2541.4

1836.3

0.29

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

370

3244

1.18

2.09

1.3

u/ml

2.0

1.7

0.10

883

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1267

13139

0.85

2.07

4.5

4.2

mmol/l

2.7

2.8

4.59

1181

12341

(3008037) Lactate [Moles/volume] in Venous blood

223

1.63

2.03

3.8

2.9

mmol/l

1.7

1.5

0.75

216

(40768797) Stomach Pathology biopsy report

191

1576

1.24

2.03

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

257

1.57

1.96

1.8

1.7

e6/l

20815.3

14992.9

0.23

194

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

105

1.92

1.96

2.3

2.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

653

0.66

1.95

1.5

1.7

mg/l

4.6

3.9

0.24

448

(3025130) Human papilloma virus identified in Specimen

187

1.67

1.94

1.6

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.74

1.93

1.0

2.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.45

1.93

3.0

2.0

umol/l

18.2

15.7

0.26

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.45

1.93

1.2

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

637

1.35

1.90

1.2

1.3

miu/ml

239.4

249.8

0.07

313

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

1.88

0.0

3.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

114

894

1.30

1.86

2.8

2.4

u/l

3176.5

5427.6

0.64

352

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

285

1.52

1.85

4.0

2.3

nmol/l

0.9

0.8

0.41

249

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

168

2026

0.81

1.84

1.3

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

206

1.61

1.83

3.5

3.0

mmol/l

7.6

7.3

0.18

201

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

336

1.47

1.81

3.3

3.5

u/ml

0.2

0.3

1.37

178

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

2.27

1.80

1.0

1.2

u/l

97.7

88.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

101

783

1.31

1.80

2.6

3.5

pmol/l

4.6

4.7

0.40

708

(3029937) Albumin [Presence] in Urine by Test strip

381

3387

1.16

1.80

4.2

3.3

estimate

0.0

1.28

123

1236

(3026389) Candida sp identified in Specimen by Organism specific culture

153

1.71

1.80

1.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

325

2856

1.17

1.78

1.4

g/l

2.5

2.3

0.87

178

1836

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.35

1.78

1.5

1.6

—

(3023410) Appearance of Cerebral spinal fluid

139

1.74

1.76

1.3

2.0

—

(3044941) Cell count panel - Synovial fluid

170

1.66

1.74

1.3

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

2.67

1.72

6.9

12.9

—

(4268621)

163

1.67

1.72

2.3

—

(3020393) Adenovirus Ag [Presence] in Stool

3.85

1.71

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

504

0.65

1.71

1.4

1.5

—

(44813793)

1.92

1.70

1.1

1.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

180

0.44

1.69

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

134

1.73

1.66

1.6

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

112

1.80

1.64

1.4

1.8

—

(40768800) Prostate Pathology biopsy report

238

0.50

1.63

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

482

1.36

1.59

1.5

1.4

—

(4015189)

3.01

1.58

1.7

4.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.70

1.58

1.6

1.2

—

(36660697) Celiac disease serology panel - Serum

139

1144

1.23

1.56

1.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

104

828

1.27

1.55

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.11

1.55

1.7

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

234

1.51

1.50

1.3

u/ml

2.0

4.7

1.13

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

228

1.50

1.44

1.4

1.3

u/ml

5.3

5.1

0.02

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

2.12

1.44

1.0

1.2

u/l

87.2

13.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

337

1.41

1.43

1.7

1.9

iu/l

6.1

5.3

0.14

122

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

353

3181

1.14

1.38

1.6

1.7

mmol/l

1.7

1.4

3.29

305

2738

(44790049)

158

1.59

1.38

1.5

1.7

—

(44806118)

158

1.59

1.38

1.5

1.7

—

(44790048)

158

1.59

1.38

1.5

1.7

—

(44790047)

158

1.59

1.38

1.5

1.7

—

(3000492) Spirometry study

167

1421

1.19

1.36

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

370

3347

1.14

1.36

1.8

1.6

—

(3023419) Bacteria identified in Sputum by Culture

151

1.60

1.35

1.5

3.1

—

(4133840)

0.00

1.34

0.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.13

1.33

2.1

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.81

1.31

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

493

1.31

1.27

1.9

2.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

121

1007

1.22

1.26

2.1

2.6

g/l

10.2

10.5

0.55

112

925

(3048689) Calprotectin [Mass/mass] in Stool

207

1808

1.17

1.26

2.4

2.5

ug/g

146.6

122.0

0.27

157

1448

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.40

1.24

2.0

3.3

—

(3042733) HLA Ab [Presence] in Serum

1.91

1.23

3.3

4.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.64

1.21

2.8

2.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

1515

15374

0.84

1.21

27.5

17.3

g/l

136.1

138.5

8.61

1504

15179

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.80

1.21

1.4

u/l

3.3

6.5

—

(3010813) Leukocytes [#/volume] in Blood

1515

15373

0.84

1.20

27.5

17.2

e9/l

7.3

6.7

14.46

1482

14980

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

614

0.74

1.20

1.4

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

140

1.58

1.20

1.3

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

205

1.47

1.20

1.1

g/l

1.5

0.53

189

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.11

1.18

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

1.88

1.18

2.3

1.6

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.88

1.18

1.3

1.1

u/l

15.3

27.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

566

0.74

1.17

1.8

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

130

0.46

1.16

1.0

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

1515

15367

0.85

1.15

27.4

17.2

e12/l

4.5

4.6

13.54

1483

14979

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

1.15

0.0

1.3

—

(3024731) MCV [Entitic volume]

1515

15365

0.85

1.13

27.3

17.1

91.0

90.2

8.28

1504

15173

(3008898) HLA-B27 [Presence]

596

0.75

1.13

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

111

0.45

1.13

2.8

1.4

—

68.6

—

(3035941) MCH [Entitic mass]

1515

15364

0.85

1.13

27.2

17.1

30.4

30.2

4.85

1504

15171

(3017569) Oxygen content in Arterial blood

1.90

1.12

2.4

3.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

329

0.66

1.11

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

251

1.40

1.11

2.5

2.3

g/l

127.6

132.7

0.47

187

(3002523) Influenza virus A Ag [Presence] in Specimen

328

0.67

1.10

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.73

1.09

1.3

2.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1454

14273

1.14

1.09

12.4

9.1

u/l

30.7

28.4

2.89

1423

13837

(3007461) Platelets [#/volume] in Blood

1514

15349

0.85

1.08

27.4

17.2

e9/l

257.4

251.7

2.62

1488

14982

(40768806) Pleura Pathology biopsy report

1.69

1.07

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.87

1.07

1.0

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.87

1.07

1.0

2.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.93

1.06

2.0

1.4

—

(3025941) Bacteria identified in Stool by Culture

771

1.22

1.04

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

212

1.42

1.04

1.5

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

255

1.38

1.03

2.5

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

106

1.61

1.03

1.6

1.3

e6/l

30625.9

126992.8

0.65

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

642

0.77

1.03

1.6

1.8

nmol/l

41.3

38.6

0.30

627

(3032773) Endomysium IgG Ab [Titer] in Serum

130

1.54

1.02

1.0

1.1

titre

—

(3041096) Erythrocytes [Presence] in Urine by Automated

341

3707

0.90

1.00

3.1

2.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

257

1.37

0.99

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

235

0.64

0.96

1.3

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

157

1.47

0.96

1.3

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1267

12370

1.10

0.93

15.6

10.5

ml/min/173m2

93.9

89.9

7.39

1054

10019

(3002385) Erythrocyte distribution width [Ratio]

1192

11605

1.09

0.93

23.1

14.3

13.7

13.5

4.05

1173

11349

(3035320) C reactive protein [Mass/volume] in Body fluid

101

1.59

0.93

2.5

2.0

—

(3045424) Erythrocytes [Presence] in Urine

221

0.63

0.93

1.2

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

142

1.48

0.92

1.5

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.73

0.92

3.1

3.0

—

(3013512) EKG study

332

3057

1.11

0.92

3.9

3.3

—

(3002619) Bacteria identified in Specimen by Culture

2.15

0.91

1.5

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

463

0.75

0.91

1.3

1.6

iu/ml

0.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

126

1.51

0.91

1.5

2.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.60

0.90

3.3

2.6

28.5

45.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

102

1.57

0.90

1.4

1.9

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

102

1.57

0.90

1.4

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

102

1.57

0.90

1.4

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.07

0.89

9.7

6.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

337

3112

1.10

0.88

2.6

umol/l

1419.5

5686.9

2.70

291

2770

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

449

1.26

0.88

2.0

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

806

1.19

0.87

1.3

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

144

1.46

0.87

1.6

1.4

mmol/l

12.1

12.7

—

(3006653) Thiamine [Moles/volume] in Blood

1.72

0.86

1.2

1.3

nmol/l

142.6

144.7

0.05

(3047007) Chlamydophila sp Ab [Presence] in Serum

227

0.66

0.84

1.1

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

467

0.77

0.83

1.8

1.9

pmol/l

198.3

210.0

0.33

444

(3028026) IgM [Mass/volume] in Serum or Plasma

801

1.18

0.83

1.6

1.8

g/l

1.2

1.4

0.84

744

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

111

0.54

0.83

1.8

1.6

g/l

1.1

1.0

—

111

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

190

0.63

0.83

2.4

4.1

u/ml

175.7

268.1

0.23

178

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.70

0.82

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

249

1.33

0.82

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

237

0.67

0.82

1.0

u/ml

2.6

2.1

—

116

(3017446) Testosterone [Moles/volume] in Serum or Plasma

123

1404

0.87

0.81

2.1

2.2

nmol/l

13.2

13.1

0.01

112

1276

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

329

1.28

0.81

1.5

1.4

—

3.0

—

(3024932) HLA-DR beta [Type]

1.73

0.79

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

732

1.18

0.78

1.5

1.4

iu/l

24.8

21.2

0.37

606

(3036481) Cortisol [Moles/volume] in Serum or Plasma

135

1193

1.14

0.76

2.1

nmol/l

371.2

379.1

0.15

125

1108

(3024471) HLA-A [Type]

1.70

0.76

1.1

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

196

0.66

0.74

4.1

3.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

167

1.38

0.73

1.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

148

1651

0.89

0.71

1.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

238

1.31

0.71

1.5

1.4

u/l

18.3

17.0

0.11

203

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.51

0.69

1.2

2.2

—

(3005033) Fetal Nuchal fold Thickness US

510

1.20

0.69

1.5

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

200

1824

1.11

0.69

1.4

titre

325.2

466.7

1.24

351

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.53

0.69

1.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.85

0.68

4.0

1.4

mmol/l

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

227

0.70

0.68

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

512

1.20

0.67

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

1.36

0.66

1.5

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

232

1.30

0.66

1.2

1.1

—

(4146454)

111

1.45

0.66

3.3

2.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.54

0.65

1.0

1.4

ug/l

7.4

7.5

0.00

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

405

0.79

0.65

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.59

0.65

1.0

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

106

935

1.14

0.64

3.9

4.1

0.7

0.6

0.14

222

(3043238) Trisomy 21 risk [Likelihood] in Fetus

524

1.19

0.64

1.6

1.5

—

(40768441) Liver Pathology biopsy report

1.48

0.64

2.0

1.5

—

(3003338) MCHC [Mass/volume]

1240

12167

1.07

0.63

25.0

14.5

g/l

334.0

334.1

0.18

1231

12072

(3012441) Differential panel - Pleural fluid

1.50

0.63

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

121

1.41

0.62

2.7

2.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.67

0.61

1.0

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.67

0.61

2.4

1.5

mmol/l

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

113

1.42

0.61

1.6

3.2

57.6

54.3

0.27

(3049717) Cytology report of Urine Cyto stain

371

1.22

0.60

2.2

2.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

139

0.65

0.60

1.7

—

(40761511) CBC panel - Blood by Automated count

1444

14261

1.09

0.60

16.5

11.0

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

0.60

0.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.60

0.0

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

0.60

0.0

3.8

—

4236.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.59

0.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

114

1018

1.13

0.59

1.2

iu/ml

102.6

149.4

0.70

397

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

112

0.62

0.58

1.1

1.6

—

(40768804) Tissue Pathology biopsy report

454

4760

0.94

0.57

2.1

2.0

—

(3000330) Specific gravity of Urine by Test strip

513

1.18

0.56

3.5

2.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

921

0.87

0.56

1.2

1.3

u/ml

179.5

244.7

0.71

858

(3020630) Protein [Mass/volume] in Serum or Plasma

768

1.14

0.54

1.9

2.5

g/l

64.6

67.0

2.47

712

(3025159) Blasts/100 leukocytes in Blood

103

920

1.13

0.54

4.4

0.0

0.1

1.52

231

(4024509)

1.43

0.53

1.4

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

187

1.29

0.53

1.5

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

489

1.17

0.52

1.3

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

161

1.31

0.52

1.5

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

607

0.85

0.51

1.7

2.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

126

1.35

0.51

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

170

1.30

0.51

1.3

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

180

0.72

0.51

1.5

1.7

mmol/l

8.4

7.3

—

113

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

188

1.28

0.51

1.0

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

135

1.34

0.51

1.3

1.1

—

(3042631) Mycobacterium sp identified in Specimen

135

1.34

0.51

2.0

3.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

807

0.87

0.50

1.3

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

124

1362

0.90

0.50

4.3

3.8

33.0

31.0

1.08

106

978

(3045683) HLA typing for celiac disease panel - Blood or Tissue

101

1.39

0.49

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

307

1.21

0.49

1.7

1.9

—

(3014271) Vancomycin [Susceptibility]

1.56

0.49

2.4

2.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

102

1.38

0.47

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

309

1.20

0.47

1.9

1.5

u/ml

103.3

114.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

309

1.20

0.47

1.3

1.2

—

(3002256) Pathology report gross observation

163

1510

1.09

0.45

1.3

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

329

1.19

0.45

1.8

1.5

—

17.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.40

0.45

2.0

3.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.40

0.44

2.5

2.3

—

(3017181) Myelocytes/100 leukocytes in Blood

112

1022

1.10

0.43

4.3

0.9

0.8

0.04

292

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

113

1.33

0.42

2.0

2.1

mg/l

11.6

19.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

517

4991

1.05

0.42

4.0

3.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

230

1.22

0.42

2.9

1.9

g/l

0.6

0.8

0.55

180

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

304

1.19

0.42

1.8

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

194

1.24

0.42

1.3

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

491

1.15

0.42

1.7

2.3

u/ml

38.6

40.6

0.03

469

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

158

1.27

0.41

1.2

1.1

89.8

95.5

0.50

151

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

286

1.19

0.41

2.4

2.5

ug/min

303.0

124.7

0.48

178

(3016038) Potassium [Moles/volume] in Urine

1.38

0.41

8.6

1.2

mmol/l

42.4

35.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.40

0.0

5.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.40

0.0

1.4

—

8.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.3

—

827.6

—

(3044007) Cell count panel - Peritoneal fluid

1.47

0.40

2.8

1.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

411

0.85

0.40

1.4

1.3

—

(40768443) Skin Pathology biopsy report

446

1.15

0.40

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

418

1.15

0.40

2.0

1.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.31

0.39

1.1

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

846

1.11

0.39

5.4

4.2

mmol/l

1.2

1.59

736

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.39

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.43

0.39

1.2

1.1

u/ml

5.7

0.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

205

1.22

0.39

2.6

2.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

1.41

0.39

1.2

3.0

u/ml

484.6

1152.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

307

1.18

0.38

1.9

1.8

—

(3033799) Differential panel - Peritoneal fluid

1.39

0.38

2.2

2.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

791

1.11

0.38

2.0

1.6

mu/l

416.9

288.7

1.18

717

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.33

0.37

1.1

1.2

—

(3019225) pH of Specimen

112

1032

1.09

0.37

3.8

4.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

158

0.76

0.37

1.0

1.4

pmol/l

36.1

241.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

134

1.27

0.37

1.5

3.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.29

0.36

1.4

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

225

2133

1.06

0.36

1.6

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.34

0.35

1.2

ratio

1.1

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.65

0.35

2.2

1.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.32

0.35

3.6

2.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

632

1.11

0.35

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

699

1.11

0.35

1.6

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.40

0.35

1.5

2.1

ug/l

64.5

66.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

330

1.16

0.34

1.8

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

634

1.11

0.34

1.5

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.33

0.33

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

635

1.11

0.33

1.5

1.4

—

(4306422)

219

1.19

0.33

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.31

0.33

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.68

0.33

1.3

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

636

1.11

0.32

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

313

1.15

0.32

1.2

2.2

g/l

9.6

10.6

0.59

276

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.28

0.32

1.2

2.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.28

0.32

1.2

2.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

105

974

1.08

0.31

4.4

4.3

0.2

0.1

0.18

271

(3034426) Prothrombin time (PT)

1.35

0.31

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

156

1.22

0.31

1.4

1.3

—

26.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.32

0.31

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.32

0.31

4.0

1.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.32

0.31

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

249

1.17

0.30

1.3

1.2

—

5.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

372

1.13

0.30

4.5

3.8

u/ml

826.6

3442.5

0.47

316

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.27

0.30

1.0

1.2

—

(3003694) ABO and Rh group [Type] in Blood

442

4292

1.04

0.29

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

109

0.73

0.29

1.0

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

110

0.73

0.29

1.0

1.3

—

(4035726)

918

0.92

0.28

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

103

1.26

0.28

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

129

0.77

0.28

2.7

2.9

nmol/l

1.0

0.9

—

100

(3008401) Mugwort IgE Ab [Units/volume] in Serum

322

0.87

0.27

1.0

1.1

u/ml

0.5

1.1

0.64

137

(3045142) Bone marrow Pathology biopsy report

119

0.76

0.27

1.1

1.3

—

(3037756) Immunofixation for Serum or Plasma

172

0.81

0.27

1.3

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

113

1.24

0.26

1.2

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.30

0.26

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.67

0.26

1.4

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

917

1.07

0.25

3.4

4.6

ug/l

15.6

25.5

0.40

742

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.23

0.25

1.1

iu/ml

148.5

212.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.22

0.25

3.3

1.4

umol/l

10.9

25.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

234

0.85

0.24

1.0

u/ml

0.0

0.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

302

1.13

0.24

6.1

6.5

iu/ml

258.5

332.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

148

0.81

0.24

2.1

2.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.25

0.24

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.25

0.24

1.1

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

327

3170

1.04

0.24

5.0

4.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1163

11515

1.03

0.24

5.9

4.8

mmol/mol

39.8

38.8

2.15

1092

10847

(3022145) Colonoscopy Study observation

129

1359

0.94

0.23

1.3

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

361

1.11

0.23

1.4

1.3

u/ml

308.5

259.0

0.51

219

(3009214) Lutropin [Units/volume] in Serum or Plasma

621

1.08

0.23

1.4

u/l

8.7

7.6

0.31

517

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

1.11

0.23

1.2

2.2

g/l

3.4

3.8

1.29

255

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

1.11

0.23

1.2

2.2

g/l

6.4

7.1

1.33

270

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

1.11

0.23

1.2

2.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

253

0.87

0.22

1.0

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.25

0.22

2.2

5.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

276

1.13

0.22

1.5

nmol/l

0.4

0.02

230

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

324

1.11

0.22

1.1

2.2

g/l

2.8

3.1

0.84

261

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.19

0.21

1.2

2.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.21

0.0

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.0

—

407.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

126.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

429

0.91

0.21

1.7

1.5

—

(4094501)

314

0.89

0.21

1.1

—

(3021788) Differential panel - Synovial fluid

192

1.15

0.20

1.6

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

644

1.07

0.20

1.3

1.2

—

(3037121) Protein [Mass/volume] in Urine

422

1.09

0.20

4.4

3.6

g/l

0.3

0.03

202

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.20

0.0

1.0

—

10.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

60.3

—

(3028433) Virus identified in Specimen by Culture

1.25

0.20

1.2

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.25

0.20

1.2

2.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

240

1.13

0.20

3.6

3.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.20

0.19

1.2

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

127

1.18

0.19

2.5

2.3

—

45.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

120

1257

0.95

0.19

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

424

1.09

0.19

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

299

1.11

0.18

1.7

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

373

0.91

0.18

1.1

u/ml

0.5

1.7

1.52

151

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.19

0.18

1.1

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.19

0.18

1.1

2.3

—

(3024263) Appearance of Synovial fluid

1.19

0.18

1.3

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.19

0.18

1.1

2.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.19

0.18

1.1

2.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

121

0.83

0.18

1.4

2.3

31.9

32.7

—

121

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.75

0.17

2.2

1.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

148

1.15

0.17

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

120

0.83

0.16

1.7

2.4

—

716.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

139

1.15

0.16

1.6

1.4

—

(3011412) CD3 cells [#/volume] in Blood

130

0.85

0.16

2.4

2.6

e9/l

1.5

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.78

0.15

1.5

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

216

1.11

0.15

1.9

2.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

419

1.08

0.15

1.4

1.7

—

201.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.81

0.14

1.6

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

337

0.92

0.14

1.0

1.1

u/ml

4.6

6.8

0.28

182

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

227

1.10

0.14

1.2

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.83

0.13

2.1

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

263

0.91

0.13

3.5

3.4

mg/l

30.8

26.2

0.13

173

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.17

0.13

1.5

1.3

—

(4027681)

106

0.85

0.13

1.1

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

104

1.15

0.12

2.0

3.0

mg/l

6.9

38.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

158

0.89

0.12

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

158

0.89

0.12

1.4

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1040

10468

0.98

0.12

3.8

3.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

222

2173

1.02

0.11

1.3

iu/ml

26.5

29.2

0.16

646

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

126

0.87

0.11

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

126

0.87

0.11

1.0

1.1

mg/l

180.5

271.2

1.63

104

(21494434) Karyotype in Bone marrow

1.16

0.11

1.0

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

270

0.92

0.10

1.0

u/ml

8.3

4.8

—

109

(1002224) Polysomnography panel

688

0.96

0.10

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.15

0.10

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

584

1.05

0.10

2.4

2.6

e6/l

0.3

0.2

0.10

564

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

183

1.09

0.10

2.0

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

156

0.90

0.10

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

156

0.90

0.10

1.4

1.5

—

(4062490)

135

1.11

0.09

1.1

1.3

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

114

0.88

0.09

1.5

1.4

nmol/l

31.8

32.7

—

102

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.06

0.09

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.06

0.09

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.06

0.09

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1306

13107

0.98

0.09

20.9

12.4

39.9

40.8

3.97

963

10406

(3006462) Nitrate [Presence] in Urine

1.11

0.09

1.5

2.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

253

1.07

0.08

1.4

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

144

0.90

0.08

1.6

1.2

—

(3017732) Neutrophils [#/volume] in Blood

884

1.03

0.08

4.1

2.8

e9/l

4.2

4.1

0.14

735

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

371

1.05

0.08

1.4

1.2

—

(3004451) EKG impression Narrative

0.82

0.08

1.8

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.83

0.08

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.79

0.08

1.0

2.4

ug/l

23.9

536.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.09

0.08

1.1

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

154

0.91

0.08

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

154

0.91

0.08

1.4

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.06

0.08

3.4

3.7

u/ml

19.4

74.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

246

0.93

0.08

1.0

1.1

u/ml

7.0

4.9

—

103

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

500

1.04

0.07

1.6

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.81

0.07

1.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

284

1.06

0.07

3.2

3.9

56.5

56.0

0.09

284

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

245

1.06

0.07

1.3

1.4

pmol/l

61.5

142.0

0.96

238

(4281824)

1.07

0.07

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

224

0.94

0.06

1.0

1.2

—

540.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

1.11

0.06

2.4

2.3

12.8

13.4

—

(40768795) Lymph node Pathology biopsy report

104

0.86

0.06

1.1

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

276

1.05

0.06

2.9

3.6

e9/l

4.3

4.1

0.15

276

(40761536) Microorganisms panel - Urine sediment

118

1159

1.02

0.05

4.1

3.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1240

12431

0.99

0.05

4.4

3.8

mmol/l

6.1

5.8

5.39

1148

11531

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

268

1.05

0.04

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

170

0.94

0.04

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

131

1.07

0.03

1.0

1.3

nmol/l

—

(3011985) Renin [Units/volume] in Plasma

139

0.93

0.03

2.4

1.4

mu/l

23.2

47.3

1.70

124

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

151

1.06

0.03

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

391

0.97

0.03

3.9

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

159

0.94

0.03

2.3

1.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

161

1.06

0.03

1.0

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

203

2046

0.99

0.03

1.3

1.2

u/ml

2.7

10.7

5.24

842

(40768793) Breast Pathology biopsy report

201

1.05

0.03

1.2

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

329

0.97

0.02

1.4

1.2

u/ml

8.5

13.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

136

0.96

0.00

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

236

0.97

0.00

1.2

1.1

—

(3022621) pH of Urine by Test strip

764

1.01

0.00

2.8

2.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

101

0.99

0.00

1.2

1.4

u/ml

0.0

0.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

111

0.99

0.00

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

111

0.99

0.00

1.2

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

194

0.98

0.00

7.6

3.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

321

1.00

0.00

1.1

u/ml

3.2

2.9

—

(3045414) Leukocytes [Presence] in Urine

531

1.00

0.00

2.2

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

102

0.98

0.00

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.02

0.00

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

112

0.98

0.00

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.0

1.2

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.00

0.00

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

61.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3013466) aPTT in Blood by Coagulation assay

0.00

0.0

1.0

—

34.3

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.95

0.00

1.1

miu/ml

1887.0

1533.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(4212803)

0.00

0.0

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.0

—

96.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.90

0.00

1.3

1.2

—

53.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.90

0.00

2.0

1.9

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

0.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.00

0.00

1.2

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

7.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.85

0.00

2.6

7.8

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1762.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.90

0.00

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

0.90

0.00

1.3

1.2

—

67.0

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

110

1.00

0.00

1.2

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.6

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.1

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.0

—

16.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

110

1.00

0.00

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.2

—

(4211845)

1.00

0.00

1.5

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.96

0.00

1.0

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

3.7

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.6

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3025315) Body weight

0.00

0.0

3.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.90

0.00

2.6

2.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.96

0.00

1.4

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

188.6

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

2.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint ST19_TOXIC_EFFECT_ETHAN and mortality.

Females

Parameter	HR [95% CI]	p-value
ST19_TOXIC_EFFECT_ETHAN	5.261 [4.21, 6.57]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.899

During the follow-up period (1.1.1998 — 31.12.2019), 320 out of 4850 females with ST19_TOXIC_EFFECT_ETHAN died.

Males

Parameter	HR [95% CI]	p-value
ST19_TOXIC_EFFECT_ETHAN	5.615 [4.99, 6.32]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1168 out of 6850 males with ST19_TOXIC_EFFECT_ETHAN died.

Mortality risk

Mortality risk for people of age

years, who have ST19_TOXIC_EFFECT_ETHAN.

N-year risk	Females	Males
1	0.708%	1.109%
5	3.474%	6.285%
10	7.41%	14.344%
15	13.925%	25.662%
20	25.639%	39.088%

Relationships between endpoints

↥

Index endpoint: ST19_TOXIC_EFFECT_ETHAN – Toxic effect of ethanol

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Toxic effect of ethanol

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints